AHA Scientific Sessions 2026 Abstract
Empagliflozin Reduces Extracellular Microvessicle Induced Endothelial Dysfunction in Patients with Ischemia with Non-Obstructive Coronary Arteries and Coronary Microvascular and Vasomotor Dysfunction
Non-randomized trial in 11 peopleEmpagliflozin